Effect of hyperimmunization with an Escherichia coli J5 bacterin in adult lactating dairy cows

Journal of the American Veterinary Medical Association

Volumn 231, Issue 7, 2007, Pages 1092-1097

  Erskine, Ronald J ^a   VanDyk, Elizabeth J ^a,b   Bartlett, Paul C ^a   Burton, Jeanne L ^a   Boyle, Michael C ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b HCS Herdenmanagement GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE, E COLI J5; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CATTLE; CATTLE DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; HOSPITALIZATION; IMMUNOLOGY; LACTATION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME;

ANIMALS; BACTERIAL VACCINES; CATTLE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; IMMUNOGLOBULIN G; LACTATION; LIPOPOLYSACCHARIDES; MASTITIS, BOVINE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ANIMALIA; BOS; ESCHERICHIA COLI;

EID: 35548984442     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.231.7.1092     Document Type: Article

References (16)

1. Cullor JS. The Escherichia coli J5 vaccine: investigating a new tool to combat coliform mastitis. Vet Med 1991;86:836-844.
2. Tyler JW, Cullor JS, Spier SJ, et al. Immunity targeting common core antigens of gram-negative bacteria. J Vet Intern Med 1990; 4:17-25.
3. Tyler JW, Cullor JS, Dellinger JD. Cross reactive affinity purification of immunoglobulin recognizing common gram-negative bacterial core antigens. J Immunol Methods 1990;129:221-226.
4. Tomita GM, Todhunter DA, Hogan JS, et al. Antigenic crossreactivity and lipopolysaccharide neutralization properties of bovine immunoglobulin G. J Dairy Sci 1995;78:2745-2752.
5. Chaiyotwittayakun A, Burton JL, Weber PSD, et al. Hyperimmunization of steers with J5 Escherichia coli bacterin: effects on isotype-specific serum antibody responses and cross reactivity with heterogenous gram-negative bacteria. J Dairy Sci 2004; 87:3375-3385.
6. Hogan JS, Smith KL, Todhunter DA, et al. Field trial to determine efficacy of an Escherichia coli J5 mastitis vaccine. J Dairy Sci 1992;75:78-84.
7. Gonzalez RN, Cullor JS, Jasper DE, et al. Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine. Can J Vet Res 1989;53:301-305.
8. Tyler JW, Cullor JS, Osburn BI, et al. Relationship between serologic recognition of Escherichia coli O111:B4 (J5) and clinical coliform mastitis in cattle. Am J Vet Res 1988;49: 1950-1954.
9. Hogan JS, Weiss WP, Todhunter DA, et al. Efficacy of an Escherichia coli J5 mastitis vaccine in an experimental challenge trial. J Dairy Sci 1992;75:415-422.
10. Tomita GM, Ray CH, Nickerson SC, et al. A comparison of two commercially available Escherichia coli J5 vaccines against E coli intramammary challenge. J Dairy Sci 2000;83:2276-2281.
11. Hill AW Vaccination of cows with rough Escherichia coli mutants fails to protect against experimental intramammary bacterial challenge. Vet Res Commun 1991;15:7-16.
12. Dosogne H, Vangroenweghe F, Burvenich C. Potential mechanism of action of J5 vaccine in protection against severe coliform mastitis. Vet Res 2002;33:1-12.
13. Kehrli ME Jr, Harp JA. Immunity in the mammary gland. Vet Clin North Am Food Anim Pract 2001;17:495-516.
14. Wilson DJ, Mallard BA, Burton JL, et al. Comparison of J-5 vaccinates and controls for clinical severity, milk production change, etiologic agent, and survival in the herd following naturally occurring cases of clinical mastitis, in Proceedings. 37th Annu Meet Am Assoc Bovine Pract 2004; 185-186.
15. Erskine RJ, Bartlett PC, VanLente JL, et al. Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle. J Dairy Sci 2002;85:2571-2575.
16. Laboratory handbook on bovine mastitis, revised edition. Verona, Wis: National Mastitis Council, 1999.